As one of the leading pharmaceutical companies in Turkey, Drogsan was established in 1975 as member of a family group “Nevzat Group of Companies” being active in the pharmaceutical industry for over 50 years with one of the oldest and largest pharma wholesale distribution chains in Turkey.
With its own in-house R&D, Production, Warehousing, Distribution, Sales / Marketing and Export facilities, Drogsan serves the world pharmaceutical industry with the global goal of a healthier future. Driven by the internal force of its vision of being a research based, value added international pharmaceutical company, Drogsan is dedicated to provide healthcare professionals with innovative quality solutions.
Drogsan’s Quality Policy ensures continuous compliance to cGMP regulations, emphasizing on Product Quality Life Management, Customer Satisfaction, Quality by Design, Productivity, and Environmental Sensibility. Standing out with its Quality Management System, Drogsan is an EU cGMP approved, ISO 9001:2008 certified organisation, with GMP approvals from Turkish MOH, Rheinland-Pfalz Landesamt Für Soziales Jugend und Versorgung - Germany, Gulf Cooperation Council (GCC), Jordan FDA, Ethiopian DACA, Nigerian NAFDAC, and DPM Cote d'Ivoire. Having gone through several successful private GMP audits, Drogsan is currently one of the contract manufacturing hubs used by European companies for Turkey.
The manufacturing site, established on a 16.500 m2 area in Çubuk-Ankara, consists of three separated production lines for solid and liquid formulations. Together with its pilot production unit, Drogsan R&D Department possesses state of art infrastructure, committed to challenge the pharmaceutical industry with innovative solutions in the field of Novel Drug Delivery Systems and clinically justified, proven unique combinations. Drogsan fully manages all of its operations under SAP/ERP system.
Drogsan offers a wide range of products in the following groups; cardiovascular, anti-hyperlipidemic, PPI, anti-infective agents, NSAID, anti-allergic, urinary system, antidiarrhea, mucolytic/ antitussive agents, cough & cold, and oral health. With the goal of keeping pace with the dynamism of global pharmaceutical industry, Drogsan continuously develops and seeks for innovative products to improve its portfolio.
Drogsan is currently present in eighteen export markets namely Azerbaijan, Georgia, Hong Kong, Jordan, Malaysia, Moldova, Vietnam, Uzbekistan, Yemen, Cambodia, Afghanistan, Myanmar, Albania, Iraq, Turkmenistan, Libya, United Arab Emirates, Kuwait with its products being currently under on-going registration process in Russia, Ukraine, South Africa, Saudi Arabia, Qatar, Kosovo, Ivory Coast, Cameroon, Congo, Gabon, Chad, Kyrgyzstan, Kazakhstan, Nigeria, Ethiopia, Tanzania, and Uganda.
With its mission of being a growing global player in the world pharmaceutical industry, Drogsan continually adds new territories to its export business and seeks for markets with high potential to contribute to its expansion.